Clinical Trial: A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463196) titled 'A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants' on Feb. 18.

Brief Summary: The main purposes of this study are:

* to investigate the safety and tolerability of ACI-19764 when it is administered to healthy participants

* to determine how quickly and to what extent ACI-19764 is absorbed, transported, metabolized, and excreted by the body (fasted and after a meal)

* to determine the effect of ACI-19764 on specific markers in the blood that are part of the immune system

The effects of ACI-19764 will be compared with the effects of a placebo. ACI-19...